CDNA

Neutral

CareDx (NASDAQ:CDNA) Upgraded at Wall Street Zen

Wall Street Zen has upgraded CareDx (NASDAQ:CDNA) from a "hold" to a "buy" rating, despite generally mixed analyst coverage which results in a consens...

MarketBeat 1 week ago 0

Bullish

Keith Kennedy to Assume Dual Role at CareDx

Keith Kennedy, the current Chief Operating Officer (COO) of CareDx Inc., will also take on the responsibilities of Chief Financial Officer (CFO), succ...

Medical Product Outsourcing 1 week ago 0

Neutral

CareDx Inc (CDNA) Shares Surge 27.6% -- What GF Score of 80 Tells Investors

CareDx Inc (CDNA) shares surged 27.6% to $22.42, marking it as "Modestly Overvalued" according to GuruFocus, with a GF Value™ of $18.98. Despite a str...

GuruFocus 2 weeks ago 0

Bullish

CareDx Divests Lab Products Business for $170M, Focuses on Precision Medicine Testing

CareDx, Inc. has announced the divestiture of its Lab Products business to EuroBio Scientific for $170 million in cash. This strategic move aims to sh...

National Today 2 weeks ago 0

Neutral

Book value per share of CareDx, Inc. – DUS:1K9

The article focuses on the book value per share of CareDx, Inc. (DUS:1K9) on the Düsseldorf Stock Exchange. It provides a financial overview and indic...

TradingView — Track All Markets 2 weeks ago 0